| Cat.No. | Name | Information |
|---|---|---|
| M1988 | Dabrafenib | Dabrafenib (free base) (GSK2118436A) is a V600 mutant BRAF-specific inhibitor. |
| M3026 | Sorafenib (BAY 43-9006) | Sorafenib (BAY 43-9006) is a multikinase inhibitor of Raf-1, B-Raf and VEGFR-2 with IC50 of 6 nM, 22 nM and 90 nM, respectively. |
| M1774 | PLX-4720 | PLX-4720 is a selective BRAFV600E inhibitor with the IC50 values of 160 nM and 130 nM for B-Raf and BRK respectively. |
| M1761 | Vemurafenib (PLX4032) | Vemurafenib (PLX4032) is a first-in-class, potent, selective inhibitor of B-Raf that inhibits RAFV600E and C-RAF-1 activity with IC50s of 31 nM and 48 nM, respectively.In addition, Vemurafenib induces autophagy. |
| M2319 | AZ628 | AZ628 is a potent inhibitor for wild-type CRAF and BRAF V600E with IC50 of 29 nM and 34 nM, respectively. |
| M1855 | Dabrafenib Mesylate | Dabrafenib (GSK2118436) is a selective, orally bioavailable inhibitor of Mutant B-raf (BRAF) protein kinase with potential antineoplastic activity. |
| M2927 | PF-04880594 | PF-04880594 is a RAF inhibitor for BRAF/BRAFV599E and c-RAF with IC50 of 0.19 nM/0.13 nM and 0.39 nM, >100-fold selectivity over CSNK1, JNK2/3 and p38. |
| M2813 | LGX818 | LGX818 is a highly potent RAF inhibitor with selective anti-proliferative and apoptotic activity in cells expressing B-RAF(V600E) with EC50 of 4 nM. |
| M2745 | GW5074 | GW5074 is a potent and selective c-Raf inhibitor with IC50 of 9 nM, no effect on the activities of JNK1/2/3, MEK1, MKK6/7, CDK1/2, c-Src, p38 MAP, VEGFR2 or c-Fms is noted. |
| M2235 | TAK-632 | TAK-632 is a potent and selective pan-RAF inhibitor. |
| M2090 | MLN2480 | MLN2480 is an orally active, CNS-permeable, highly selective inhibitor of type II RAF kinase that inhibits both monomeric (class I mutant) and dimeric forms of RAF and does not cause aberrant activation of the MAPK pathway caused by type I RAF inhibitors. In addition, MLN2480 inhibits the growth of tumors harboring BRAF fusions or BRAF V600 mutations and can be used in studies related to gliomas. |
| M2045 | CEP-32496 | CEP-32496 is a potent orally active BRAF inhibitor with IC50 of 14 nM. |
| M1863 | RAF265 | RAF265 is a novel, orally bioavailable dual inhibitor of RAF kinase and VEGFR2. |
| M1818 | ZM 336372 | ZM 336372 is a potent, selective ATP-competitive inhibitor of c-Raf in vitro (IC50 = 70 nM for inhibition of human c-Raf). |
| M1783 | SB590885 | SB590885 is a selective small-molecule inhibitor of the B-Raf kinase and Ki values are 0.16 and 1.72 nM for B-Raf and c-Raf respectively. |
| M1714 | GDC-0879 | GDC-0879 is a potent and selective B-Raf kinase inhibitor with an EC50 of 0.75 µM. |
| M52907 | Cyclorasin 9A5 | Cyclorasin 9A5 is an 11-residue cell-permeable cyclic peptide that orthosterically inhibits the Ras-Raf protein interaction with an IC50 of 120 nM. |
| M52812 | R18 | R18 is a peptide antagonists of 14-3-3, with a KD of 70-90 nM. |
| M43467 | PROTAC RAF degrader 1 | PROTAC RAF degrader 1 is a PROTAC RAF degrader. |
| M42156 | B-Raf IN 15 | B-Raf IN 15 is a BRAF inhibitor. |
| M42155 | Raf inhibitor 3 | Raf inhibitor 3 is a Raf inhibitor. |
| M42154 | B-Raf IN 16 | B-Raf IN 16 is a BRAF inhibitors that belongs a cyclic iminopyrimidine derivative. |
| M42153 | B-Raf IN 13 | B-Raf IN 13 is a BRAF inhibitor with an IC50 of 3.55 nM in BRAF V600E enzyme assay. |
| M42152 | Vem-L-Cy5 | Vem-L-Cy5, modified with the NIR fluorophore cyanine-5 (Cy5), is a Vemurafenib-based inhibitor of BRAF. |
| M30908 | BRAF inhibitor | BRAF inhibitor is a B-Raf inhibitor. |
| M30907 | B-Raf IN 11 | B-Raf IN 11 (ZINC72115182) is a selective B-RafV600E inhibitor (IC50=76 nM), shows selectivity for B-RafV600E over B-RafWT with selectivity of 3.1-fold. B-Raf IN 11 can be used in colorectal cancer research[1] |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
